Alexis Peyroles
Chief Operating Officer, in charge of Finance, Bus
Business Management
OSE immuno therapetics
France
Biography
Alexis Peyroles has more than 15 years of management and financial control experience, having served in related positions, internationally. Alexis Peyroles joined Sanofi-Aventis in 1996, working first as Financial Controller in Japan before becoming Head of financial control for the Baltic states. He was subsequently named Head of activities for Business Development in Eastern Europe. In 2005, he joined the Guerbet group (a leader in the field of contrast products, especially in medical imaging) as Financial Control Manager and in 2009, became Chief Executive Officer for Latin America, based in Brazil. As soon as 2013, Alexis Peyroles has been involved in OSE Pharma and served as Chief Financial Officer and was in charge of Business Development. Upon the merger of OSE Pharma with Effimune in May 2016, he was appointed Chief Operating Officer of OSE Immunotherapeutics, in charge of Finance, Business Development and Operations. Alexis Peyroles graduated from EDHEC Business School and holds an Imperial Executive MBA.
Research Interest
Business Management
